Management of Chemotherapy-Induced Nausea and Vomiting

The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy

(2013) Rudolph M. Navari et al.   SUPPORTIVE CARE IN CANCER

Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin-based chemotherapy

(2012) F. Longo et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study

(2012) Costantine Albany et al.   JOURNAL OF CLINICAL ONCOLOGY

Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE

(2011) Steven Grunberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

(2011) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study

(2011) Felipe Melo Cruz et al.   SUPPORTIVE CARE IN CANCER

A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy

(2011) Kenjiro Aogi et al.   SUPPORTIVE CARE IN CANCER

Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study

(2011) Paul J. Hesketh et al.   SUPPORTIVE CARE IN CANCER

Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients

(2011) Julie L. Ryan et al.   SUPPORTIVE CARE IN CANCER

Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy

(2010) M. Aapro et al.   ANNALS OF ONCOLOGY

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

(2010) F. Roila et al.   ANNALS OF ONCOLOGY

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer

(2010) Rudolph M Navari   Future Oncology

Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy

(2010) Anu Kochanujan Pillai et al.   PEDIATRIC BLOOD & CANCER

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

(2010) Luigi Celio et al.   SUPPORTIVE CARE IN CANCER

Efficacy and Tolerability of Gastric-retentive Gabapentin for the Treatment of Postherpetic Neuralgia

(2009) Gordon Irving et al.   CLINICAL JOURNAL OF PAIN

Aprepitant

(2009) Monique P. Curran et al.   DRUGS

Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting

(2009) Rudolph M. Navari   DRUGS

Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant

(2009) Kamalesh K Sankhala et al.   Expert Opinion on Drug Metabolism & Toxicology

Phase III Trial of Casopitant, a Novel Neurokinin-1 Receptor Antagonist, for the Prevention of Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy

(2009) Jørn Herrstedt et al.   JOURNAL OF CLINICAL ONCOLOGY

Whole brain radiotherapy with radiosensitizer for brain metastases

(2009) Gustavo Viani et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial

(2009) Steven M Grunberg et al.   LANCET ONCOLOGY

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

(2009) Mitsue Saito et al.   LANCET ONCOLOGY

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study

(2009) Bernardo L. Rapoport et al.   SUPPORTIVE CARE IN CANCER

Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting

(2008) Suzanna M. Zick et al.   SUPPORTIVE CARE IN CANCER